After Hours
There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Stocks Info
This NYSE-listed company operates within the Medical Devices industry segment, falling under the Healthcare sector. The current market capitalization of Globus Medical Inc is $8.95B. A total of 1.08 million shares were traded on the day, compared to an average of 1.17M shares.
In the most recent transaction, Lemaitre Dan sold 63,300 shares of GMED for 64.61 per share on May 10 ’24. After the transaction, the Director now owns 0 company shares. In a previous transaction on May 08 ’24, Davidar David D sold 20,000 shares at 65.00 per share. GMED shares that Director owns now total 566,275.
Among the insiders who sold shares, Norwalk Leslie V disposed of 10,590 shares on Mar 15 ’24 at a per-share price of $51.99. This resulted in the Director holding 17,419 shares of GMED after the transaction. In another insider transaction, Huller Kelly sold 7,500 shares at $54.10 per share on Mar 01 ’24. Company shares held by the SVP, GC, Corporate Secretary now total 0.
Even though price targets are rarely accurate, they do tend to exert some kind of influence from time to time and are often considered important by markets. In terms of 52-week highs and lows, GMED has a high of $65.74 and a low of $43.38.
Balance Sheet Annually/Quarterly
In a balance sheet, you can see what assets and liabilities the company has, as well as how much equity investors have invested. These figures can be used to calculate a company’s financial ratios to give investors a better idea of its prospects. GMED’s latest balance sheet shows that the firm has $443.45M in Cash & Short Term Investments as of fiscal 2021. Its Book Value Per Share was $29.04, while its Total Shareholder’s Equity was $1.74B.
Analysts Opinion
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for GMED is Buy with a score of 3.80.
